SEC Form 4 · accession 0001078782-17-000337
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacob Vincent Micallef
Officer — Chief Scientific Officer
Period of report
Mar 17, 2017
Accepted (ET)
Mar 21, 2017 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (Right to Buy)F1 | $2.60 | Mar 17, 2017 | S | 5,000 | D | May 11, 2012 | May 10, 2017 | Common Stock | 5,000 | 0 | I |
Explanation of responses
- F1The Warrant is held directly by Borlaug Limited. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issuable upon the exercise of the Warrant. Dr. Micallef disclaims beneficial ownership of the shares of Common Stock issuable upon the exercise of the Warrant, except to the extent of his pecuniary interest.